Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial

Publication Date

2025

Content Type

Article

PubMed ID:

40779733

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS